JAMES F POLEWACZYK Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES F POLEWACZYK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES F POLEWACZYK. JAMES F POLEWACZYK is Corporate Vice President in IDEXX LABORATORIES INC /DE ($IDXX) and Executive Vice President in IDEXX LABORATORIES INC /DE ($IDXX).
Latest Insider Trading Transactions of JAMES F POLEWACZYK
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 67.85 | 10,000 | 678,500 | 2,627 | |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 565.56 | 200 | 113,111 | 19,915 | 20.1 K to 19.9 K (-0.99 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 564.73 | 513 | 289,704 | 20,115 | 20.6 K to 20.1 K (-2.49 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 564.04 | 1,713 | 966,198 | 20,628 | 22.3 K to 20.6 K (-7.67 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 562.65 | 2,462 | 1,385,253 | 22,341 | 24.8 K to 22.3 K (-9.93 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 561.77 | 1,429 | 802,771 | 24,803 | 26.2 K to 24.8 K (-5.45 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 560.79 | 1,274 | 714,451 | 26,232 | 27.5 K to 26.2 K (-4.63 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 559.77 | 1,370 | 766,879 | 27,506 | 28.9 K to 27.5 K (-4.74 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 558.89 | 1,039 | 580,690 | 28,876 | 29.9 K to 28.9 K (-3.47 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 67.85 | 10,000 | 678,500 | 29,915 | 19.9 K to 29.9 K (+50.21 %) |
| Mar 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 67.85 | 1,476 | 100,147 | 0 | |
| Mar 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 67.85 | 1,476 | 100,147 | 19,903 | 18.4 K to 19.9 K (+8.01 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 217 | 0 | 2,074 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,291 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,418 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 150 | 0 | 2,544 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 243 | 0 | 2,694 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 2,937 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 257 | 139,829 | 18,427 | 18.7 K to 18.4 K (-1.38 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 217 | 0 | 18,684 | 18.5 K to 18.7 K (+1.18 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 18,467 | 18.3 K to 18.5 K (+0.69 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 18,340 | 18.2 K to 18.3 K (+0.69 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 18,340 | 18.2 K to 18.3 K (+0.69 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 150 | 0 | 18,214 | 18.1 K to 18.2 K (+0.83 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 243 | 0 | 18,064 | 17.8 K to 18.1 K (+1.36 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 64.24 | 4,028 | 258,759 | 0 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 79.54 | 11,110 | 883,689 | 0 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 62.00 | 1,126 | 69,812 | 0 | |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 299.30 | 4,028 | 1,205,559 | 17,772 | 21.8 K to 17.8 K (-18.48 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 64.24 | 4,028 | 258,759 | 21,800 | 17.8 K to 21.8 K (+22.66 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 298.75 | 11,110 | 3,319,088 | 17,772 | 28.9 K to 17.8 K (-38.47 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 79.54 | 11,110 | 883,689 | 28,882 | 17.8 K to 28.9 K (+62.51 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 298.29 | 1,126 | 335,869 | 17,772 | 18.9 K to 17.8 K (-5.96 %) |
| May 12 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 62.00 | 1,126 | 69,812 | 18,898 | 17.8 K to 18.9 K (+6.34 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,294 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,421 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 150 | 0 | 2,547 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 243 | 0 | 2,697 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 207 | 0 | 2,940 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 0.00 | 866 | 0 | 3,147 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 288.78 | 8,906 | 2,571,875 | 8,906 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Payment of Exercise | F | 288.78 | 259 | 74,794 | 16,493 | 16.8 K to 16.5 K (-1.55 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 16,752 | 16.6 K to 16.8 K (+0.76 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 16,625 | 16.5 K to 16.6 K (+0.76 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 150 | 0 | 16,499 | 16.3 K to 16.5 K (+0.92 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 243 | 0 | 16,349 | 16.1 K to 16.3 K (+1.51 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 207 | 0 | 16,106 | 15.9 K to 16.1 K (+1.30 %) |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 2,000 | 0 | 5,174 | |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 258 | 0 | 3,174 | |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 716 | 0 | 3,432 | |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 34.37 | 17,837 | 613,058 | 17,837 | |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 34.37 | 2,913 | 100,120 | 2,913 | |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Payment of Exercise | F | 34.37 | 366 | 12,579 | 1,055 | 1.4 K to 1.1 K (-25.76 %) |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 258 | 0 | 1,421 | 1.2 K to 1.4 K (+22.18 %) |
| Feb 18 2009 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 716 | 0 | 1,163 | 447 to 1.2 K (+160.18 %) |
| Feb 19 2008 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 1,288 | 0 | 4,148 | |
| Feb 19 2008 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 716 | 0 | 2,860 | |
| Feb 19 2008 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 56.95 | 6,004 | 341,928 | 6,004 | |
| Feb 19 2008 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 56.95 | 8,775 | 499,736 | 8,775 | |
| Feb 19 2008 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Payment of Exercise | F | 56.95 | 269 | 15,320 | 447 | 716 to 447 (-37.57 %) |
| Feb 19 2008 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Buy | M | 0.00 | 716 | 0 | 716 | 0 to 716 |
| Feb 16 2007 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 1,788 | 0 | 1,788 |
Page: 1